ACCELERATE substudy shows no benefit of evacetrapib in patients with diabetes
Trial stopped early after evacetrapib fails to budge event rate
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy